Stelara



Indications and Reactions:

Role Indications Reactions
Primary
Psoriasis 63.6%
Product Used For Unknown Indication 16.5%
Psoriatic Arthropathy 4.0%
Hypertension 3.3%
Diabetes Mellitus 1.8%
Ill-defined Disorder 1.6%
Prophylaxis 1.4%
Depression 1.4%
Pain 1.2%
Pustular Psoriasis 0.8%
Drug Use For Unknown Indication 0.7%
Crohn's Disease 0.6%
Anxiety 0.5%
Hyperlipidaemia 0.5%
Hypothyroidism 0.4%
Blood Cholesterol Increased 0.4%
Pruritus 0.4%
Blood Cholesterol 0.3%
Arthritis 0.3%
Asthma 0.3%
Psoriasis 15.8%
Myocardial Infarction 12.8%
Pneumonia 9.6%
Cerebrovascular Accident 5.5%
Cellulitis 4.6%
Psoriatic Arthropathy 4.6%
Pustular Psoriasis 4.4%
Off Label Use 4.2%
Prostate Cancer 4.2%
Weight Decreased 4.0%
Headache 3.8%
Death 3.8%
Herpes Zoster 3.4%
Drug Ineffective 3.4%
Weight Increased 3.0%
Tuberculosis 3.0%
Breast Cancer 2.5%
Hepatic Enzyme Increased 2.4%
Hepatic Function Abnormal 2.4%
Liver Function Test Abnormal 2.4%
Secondary
Psoriasis 73.1%
Product Used For Unknown Indication 7.9%
Psoriatic Arthropathy 6.4%
Hypertension 2.5%
Prophylaxis 1.9%
Crohn's Disease 1.9%
Diabetes Mellitus 1.0%
Ill-defined Disorder 0.9%
Pustular Psoriasis 0.8%
Depression 0.6%
Hyperlipidaemia 0.5%
Pain 0.4%
Folliculitis 0.4%
Anticoagulant Therapy 0.3%
Convulsion Prophylaxis 0.2%
Hyperuricaemia 0.2%
Asthma 0.2%
Hypothyroidism 0.2%
Contraception 0.2%
Hidradenitis 0.2%
Psoriasis 20.6%
Hepatic Function Abnormal 8.7%
Cellulitis 6.7%
Myocardial Infarction 6.2%
Pneumonia 5.7%
Drug Ineffective 4.9%
Off Label Use 4.9%
Psoriatic Arthropathy 4.9%
Cerebrovascular Accident 3.9%
Neck Pain 3.9%
Weight Decreased 3.7%
Liver Disorder 3.6%
Syncope 3.1%
Nasopharyngitis 2.9%
Type 2 Diabetes Mellitus 2.9%
Gamma-glutamyltransferase Increased 2.8%
Condition Aggravated 2.7%
Gastroenteritis 2.7%
Liver Function Test Abnormal 2.7%
Staphylococcal Infection 2.6%
Concomitant
Psoriasis 51.9%
Product Used For Unknown Indication 13.3%
Psoriatic Arthropathy 10.5%
Anxiety 4.6%
Depression 3.9%
Crohn's Disease 2.8%
Post Concussion Syndrome 2.6%
Prophylaxis 1.5%
Pain 1.1%
Rheumatoid Arthritis 1.1%
Vitamin Supplementation 1.1%
Hypertension 0.9%
Post-traumatic Pain 0.9%
Thyroid Disorder 0.9%
Hypersensitivity 0.7%
Parkinson's Disease 0.7%
Acute Psychosis 0.4%
Dyspepsia 0.4%
Hypothyroidism 0.4%
Low Density Lipoprotein Increased 0.4%
Psoriasis 37.7%
Drug Ineffective 20.3%
Therapeutic Response Decreased 9.4%
Skin Plaque 4.3%
Pancreatic Carcinoma 2.9%
Pancreatitis 2.9%
Psoriatic Arthropathy 2.9%
Weight Decreased 2.2%
Acute Psychosis 1.4%
Arthritis 1.4%
Crohn's Disease 1.4%
Drug Interaction 1.4%
Gastrointestinal Haemorrhage 1.4%
Headache 1.4%
Hypertension 1.4%
Injection Site Pain 1.4%
Prostate Cancer 1.4%
Pyrexia 1.4%
Rash 1.4%
Skin Exfoliation 1.4%
Interacting
Psoriasis 90.0%
Hyperlipidaemia 10.0%
Psoriasis 57.1%
Ataxia 14.3%
Drug Level Increased 14.3%
Myalgia 14.3%